Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1999-7-12
pubmed:abstractText
Many patients with advanced NHL ultimately relapse and require salvage treatment. Oxaliplatin, a diaminocyclohexane (DACH) platinum, has shown a differential spectrum of cytotoxicity with cisplatin, with activity in primary or secondary cisplatin-resistant solid tumors (colon and ovarian cancer). We report the tolerance/activity of this platinum derivate in previously-treated NHL patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0923-7534
pubmed:author
pubmed:issnType
Print
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
351-4
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:10355582-Adult, pubmed-meshheading:10355582-Aged, pubmed-meshheading:10355582-Antineoplastic Agents, pubmed-meshheading:10355582-Dose-Response Relationship, Drug, pubmed-meshheading:10355582-Drug Administration Schedule, pubmed-meshheading:10355582-Drug Resistance, Neoplasm, pubmed-meshheading:10355582-Female, pubmed-meshheading:10355582-Humans, pubmed-meshheading:10355582-Infusions, Intravenous, pubmed-meshheading:10355582-Lymphoma, Non-Hodgkin, pubmed-meshheading:10355582-Male, pubmed-meshheading:10355582-Middle Aged, pubmed-meshheading:10355582-Neoplasm Recurrence, Local, pubmed-meshheading:10355582-Organoplatinum Compounds, pubmed-meshheading:10355582-Pilot Projects, pubmed-meshheading:10355582-Prognosis, pubmed-meshheading:10355582-Salvage Therapy, pubmed-meshheading:10355582-Treatment Outcome
pubmed:year
1999
pubmed:articleTitle
Preliminary results on the activity of oxaliplatin (L-OHP) in refractory/recurrent non-Hodgkin's lymphoma patients.
pubmed:affiliation
Fédération des Maladies Sanguines, Immunitaires et Tumorales, Hôpital Paul Brousse, Villejuif, France.
pubmed:publicationType
Journal Article, Clinical Trial